Ecological Momentary Assessment of State-Dependent Decision-Making and Metacognition Across a Psychopathology Continuum
Public ClinicalTrials.gov record NCT07801079. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Background: Life experiences could impact how one feel, and in turn alter how decisions are made. For example, an argument with a loved one might lead to frustration that drives one to seek alcohol or engage in other riskier decision-making. By tracking not only how life experiences might change feelings but also the decision-making tendencies assessed by behavioral tasks, researcher aimed to better understand naturalistically how life experiences might shape behaviors through feelings. This could lead to a better understanding, identification and treatment for people with mental disorders. Objective: Naturalistically track how life experiences change self-reported mental states, such as emotions or mood, as well as decision-making tendencies. Eligibility: Individuals aged 18 to 55 years, who are either healthy or with varying degrees of depressive, anxious or addictive symptom severity. Design: Participants in the study will complete the following activities: 1) complete an initial assessment of their medical, mental health and personal history; 2) complete a set of behavior tasks; 3) for 12 weeks, complete surveys, tasks and audiovisual diary on a smart phone while they go about their life; 4) for 12 weeks, continuously wear an smartwatch-like device to track physiological signals; 5) every 2 weeks for 12 weeks, complete a set of surveys on mental health conditions; and 6) complete an end-of-study debriefing session to discuss their experience in the study.
Study identification
- NCT ID
- NCT07801079
- Recruitment status
- Not yet recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 420 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 18, 2026
- Primary completion
- Aug 18, 2031
- Completion
- Aug 19, 2032
- Last update posted
- Sep 2, 2026
2026 – 2032
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07801079, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 2, 2026 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07801079 live on ClinicalTrials.gov.